Clinical trial
ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study
NCT06846736
Study timeline
Study start (actual)2023-08-13Date precision: day
Registry last updated2025-02-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alk-positive Non-Small Cell Lung Cancerunresolved
ALK-inhibitor Treatedunresolved
Interventions
Sponsors & collaborators
Sheba Medical Centerlead sponsor
Mayo Cliniccollaborator
Gustave Roussy, Cancer Campus, Grand Pariscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06846736 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.